Eton Pharmaceuticals, Inc.

NasdaqGM:ETON Stock Report

Mkt Cap: US$101.0m

Eton Pharmaceuticals Financial Health

Financial Health criteria checks 5/6

Eton Pharmaceuticals has a total shareholder equity of $11.2M and total debt of $6.4M, which brings its debt-to-equity ratio to 57.3%. Its total assets and total liabilities are $23.9M and $12.7M respectively.

Key information

57.3%

Debt to equity ratio

US$6.45m

Debt

Interest coverage ration/a
CashUS$14.71m
EquityUS$11.24m
Total liabilitiesUS$12.69m
Total assetsUS$23.93m

Recent financial health updates

Is Eton Pharmaceuticals (NASDAQ:ETON) Using Debt In A Risky Way?

Dec 22
Is Eton Pharmaceuticals (NASDAQ:ETON) Using Debt In A Risky Way?

Eton Pharmaceuticals (NASDAQ:ETON) Is Using Debt Safely

Oct 14
Eton Pharmaceuticals (NASDAQ:ETON) Is Using Debt Safely

Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?

Apr 05
Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?

Recent updates

Is Eton Pharmaceuticals (NASDAQ:ETON) Using Debt In A Risky Way?

Dec 22
Is Eton Pharmaceuticals (NASDAQ:ETON) Using Debt In A Risky Way?

Eton Pharmaceuticals acquires FDA-approved rare disease product betaine anhydrous

Sep 13

Eton Pharmaceuticals: An Evolving 'Sum Of The Parts' Story

Aug 14

Eton Pharma jumps 20% on FDA approval of seizure therapy

Jul 18

Broker Revenue Forecasts For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Are Surging Higher

Apr 15
Broker Revenue Forecasts For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Are Surging Higher

Eton Pharmaceuticals (NASDAQ:ETON) Is Using Debt Safely

Oct 14
Eton Pharmaceuticals (NASDAQ:ETON) Is Using Debt Safely

Another Look At Eton Pharmaceuticals

Sep 03

What Does The Future Hold For Eton Pharmaceuticals, Inc. (NASDAQ:ETON)? These Analysts Have Been Cutting Their Estimates

Aug 18
What Does The Future Hold For Eton Pharmaceuticals, Inc. (NASDAQ:ETON)? These Analysts Have Been Cutting Their Estimates

Eton Pharma wins FDA approval for Rezipres

Jun 15

FDA declines to approve Eton Pharmaceuticals' methanol poisoning treatment

May 28

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Is About To Turn The Corner

May 15
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Is About To Turn The Corner

Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?

Apr 05
Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?

Could The Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Ownership Structure Tell Us Something Useful?

Mar 01
Could The Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Ownership Structure Tell Us Something Useful?

Eton Pharma buys Canadian rights for Alkindi Sprinkle

Jan 14

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Shift From Loss To Profit

Jan 07
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Shift From Loss To Profit

FDA accepts Eton application for Topiramate for partial seizures

Dec 17

Eton Pharmaceuticals announces availability of ALKINDI SPRINKLE in U.S.

Nov 24

Do Insiders Own Lots Of Shares In Eton Pharmaceuticals, Inc. (NASDAQ:ETON)?

Jul 06
Do Insiders Own Lots Of Shares In Eton Pharmaceuticals, Inc. (NASDAQ:ETON)?

Financial Position Analysis

Short Term Liabilities: ETON's short term assets ($19.1M) exceed its short term liabilities ($7.5M).

Long Term Liabilities: ETON's short term assets ($19.1M) exceed its long term liabilities ($5.2M).

Debt to Equity History and Analysis

Debt Level: ETON has more cash than its total debt.

Reducing Debt: ETON's debt to equity ratio has increased from 0% to 57.3% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ETON has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ETON has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 16% each year

Discover healthy companies